免疫遗传学市场（2026—2031）
免疫遗传学市场规模预计由2026年的67.7亿美元增至2031年的105.1亿美元，预测期复合年增长率为9.20%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
免疫遗传学市场规模预计由2026年的67.7亿美元增至2031年的105.1亿美元，预测期复合年增长率为9.20%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 9.2% | 机构预测 |
| 市场规模 | 2026 | USD 6.77 billion | 机构预测 |
| 市场规模 | 2031 | USD 10.51 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | solid-organ transplantation | 2025 | 66.780% |
| end_user | hospitals and transplant centers | 2025 | 55.890% |
| geography | North America | 2025 | 41.230% |
| product_and_service_type | reagents and consumables | 2025 | 51.670% |
| technology | molecular assays | 2025 | 55.450% |
关键结论
- application 维度中，solid-organ transplantation 在 2025 年的公开份额为 66.78%。
- end_user 维度中，hospitals and transplant centers 在 2025 年的公开份额为 55.89%。
- geography 维度中，North America 在 2025 年的公开份额为 41.23%。
- product_and_service_type 维度中，reagents and consumables 在 2025 年的公开份额为 51.67%。
- technology 维度中，molecular assays 在 2025 年的公开份额为 55.45%。
主要参与者
- QIAGEN N.V.
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- CareDx, Inc.
- Omixon, Inc.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising solid-organ and HSCT transplant volumes | +2.500% | Global | Short term (≤ 2 years) |
| Expansion of high-resolution NGS-based HLA typing | +2.000% | Global, concentrated in North America and Europe | Medium term (2-4 years) |
| Growing use of HLA testing in pharmacogenomics and companion diagnostics | +1.200% | North America, Europe, and East Asia | Medium term (2-4 years) |
| Expansion of donor registries and transplant infrastructure | +0.700% | Asia-Pacific, Middle East and Africa, and South America | Long term (≥ 4 years) |
| HLA and KIR complexity driving allele-level resolution | +0.600% | Global, especially Asia-Pacific and underrepresented populations | Medium term (2-4 years) |
| Faster deceased-donor workflows through long-read sequencing | +0.500% | North America, Europe, and advanced Asia-Pacific markets | Medium term (2-4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| High cost of molecular testing | -1.500% | Global, especially Middle East and Africa, South America, and Tier-2 Asia-Pacific markets | Medium term (2-4 years) |
| Sequencing infrastructure cost and capacity barriers | -1.500% | Global, especially Middle East and Africa, South America, and Tier-2 Asia-Pacific markets | Medium term (2-4 years) |
| Uneven reimbursement for high-resolution HLA testing | -1.000% | Global, concentrated in Europe, Asia-Pacific, and Middle East and Africa | Medium term (2-4 years) |
| Regulatory requirements across countries | -1.000% | Global, concentrated in Europe, Asia-Pacific, the Middle East and Africa | Medium term (2-4 years) |
报告关注的关键问题
What is the projected value of immunogenetics by 2031?
The immunogenetics market is projected to reach USD 10.51 billion by 2031, from USD 6.77 billion in 2026, at a 9.20% CAGR.
What is driving demand for immunogenetics testing?
Higher solid-organ and allogeneic stem-cell transplant activity, together with high-resolution HLA typing adoption, supports demand in the immunogenetics market.
Which product category leads immunogenetics revenue?
Reagents and consumables led revenue with a 51.67% share in 2025, supported by recurring NGS material needs across the immunogenetics market.
Which immunogenetics technology is growing the fastest?
Molecular assays recorded the highest projected CAGR at 10.46% through 2031, supported by NGS and long-read sequencing adoption in the immunogenetics market.
Which application uses the most immunogenetics testing?
Solid-organ transplantation held 66.78% of application revenue in 2025 and remains the largest use area in the immunogenetics market.
Which region is expanding fastest for immunogenetics testing?
Asia-Pacific is projected to expand at a 12.98% CAGR through 2031 as transplant capacity and local diagnostic infrastructure develop.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence